绝经后骨质疏松症的药物治疗 - Suppr

Pharmacotherapy for Postmenopausal Osteoporosis.

出版信息

JAMA. 2021 May 11;325(18):1888-1889. doi: 10.1001/jama.2020.13841.

DOI:10.1001/jama.2020.13841

PMID:33974021

Abstract

摘要

相似文献

Pharmacotherapy for Postmenopausal Osteoporosis.

JAMA. 2021 May 11;325(18):1888-1889. doi: 10.1001/jama.2020.13841.

Autonomy begets adherence: decisions to start and persist with osteoporosis treatment after group medical consultation.

Arch Osteoporos. 2020 Sep 5;15(1):138. doi: 10.1007/s11657-020-00809-1.

[Pharmacotherapy of osteoporosis in ambulatory practice and its pharmaceutical aspects].

Ceska Slov Farm. 2001 Jul;50(4):188-92.

2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis.

Joint Bone Spine. 2012 May;79(3):304-13. doi: 10.1016/j.jbspin.2012.02.014. Epub 2012 Apr 19.

[Advances in the pharmacotherapy of osteoporosis].

Vnitr Lek. 1995 Mar;41(3):207-9.

Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines.

Ann Pharmacother. 2015 Sep;49(9):995-1003. doi: 10.1177/1060028015588127. Epub 2015 Jun 3.

Compliance with osteoporosis treatment guidelines in postmenopausal women.

Ann Pharmacother. 2009 Feb;43(2):242-50. doi: 10.1345/aph.1L464. Epub 2009 Feb 5.

Present and future pharmacotherapy for osteoporosis.

Drugs Today (Barc). 2003 Aug;39(8):633-57. doi: 10.1358/dot.2003.39.8.799409.

Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.

Curr Med Res Opin. 2013 Mar;29(3):205-16. doi: 10.1185/03007995.2013.763779. Epub 2013 Jan 25.

2018 update of French recommendations on the management of postmenopausal osteoporosis.

Joint Bone Spine. 2018 Oct;85(5):519-530. doi: 10.1016/j.jbspin.2018.02.009. Epub 2018 Apr 11.

引用本文的文献

Rational polyelectrolyte nanoparticles endow preosteoclast-targeted siRNA transfection for anabolic therapy of osteoporosis.

Sci Adv. 2023 Mar 10;9(10):eade7379. doi: 10.1126/sciadv.ade7379. Epub 2023 Mar 8.

Is abaloparatide more efficacious on increasing bone mineral density than teriparatide for women with postmenopausal osteoporosis? An updated meta-analysis.

J Orthop Surg Res. 2023 Feb 17;18(1):116. doi: 10.1186/s13018-023-03595-x.

MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP1.

Cell Death Discov. 2022 Nov 29;8(1):470. doi: 10.1038/s41420-022-01261-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Pharmacotherapy for Postmenopausal Osteoporosis.

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献